Other Species / Isoforms
  CDC5L (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K25-ub
ILKAAVMkYGKNQWS
0 1
CDC5L (human) ILKAAVMkYGKNQWS K25-ub
CDC5L (mouse) ILKAAVMKYGKNQWS K25
CDC5L (rat) ILKAAVMKYGKNQWS K25
K41-m1
IASLLHRkSAKQCKA
0 1
CDC5L (human) IASLLHRkSAKQCKA K41-m1
CDC5L (mouse) IASLLHRKSAKQCKA K41
CDC5L (rat) IASLLHRKSAKQCKA K41
K59-ub
EWLDPSIkKTEWSRE
0 2
CDC5L (human) EWLDPSIkKTEWSRE K59-ub
CDC5L (mouse) EWLDPSIKKTEWSRE K59
CDC5L (rat) EWLDPSIKKTEWSRE K59
K70-ub
WSREEEEkLLHLAKL
0 2
CDC5L (human) WSREEEEkLLHLAKL K70-ub
CDC5L (mouse) WSREEEEKLLHLAKL K70
CDC5L (rat) WSREEEEKLLHLAKL K70
K165-m1
RLANTQGkkAkRKAR
0 2
CDC5L (human) RLANTQGkkAkRKAR K165-m1
CDC5L (mouse) RLANTQGKKAKRKAR K165
CDC5L (rat) RLANTQGKKAKRKAR K165
K166-ac
LANTQGkkAkRKARE
0 1
CDC5L (human) LANTQGkkAkRKARE K166-ac
CDC5L (mouse) LANTQGKKAKRKARE K166
CDC5L (rat) LANTQGKKAKRKARE K166
K168-ac
NTQGkkAkRKAREKQ
0 1
CDC5L (human) NTQGkkAkRKAREKQ K168-ac
CDC5L (mouse) NTQGKKAKRKAREKQ K168
CDC5L (rat) NTQGKKAKRKAREKQ K168
K187-ub
RRLAALQkRRELRAA
0 1
CDC5L (human) RRLAALQkRRELRAA K187-ub
CDC5L (mouse) RRLAALQKRRELRAA K187
CDC5L (rat) RRLAALQKRRELRAA K187
Y210-p
KRKRGVDyNAEIPFE
0 2
CDC5L (human) KRKRGVDyNAEIPFE Y210-p
CDC5L (mouse) KKKRGVDYNAEIPFE Y210
CDC5L (rat) KKKRGVDYNAEIPFE Y210
K219-ub
AEIPFEKkPALGFyD
0 1
CDC5L (human) AEIPFEKkPALGFyD K219-ub
CDC5L (mouse) AEIPFEKKPALGFYD K219
CDC5L (rat) AEIPFEKKPALGFYD K219
K219-sm
AEIPFEKkPALGFyD
0 1
CDC5L (human) AEIPFEKkPALGFyD K219-sm
CDC5L (mouse) AEIPFEKKPALGFYD K219
CDC5L (rat) AEIPFEKKPALGFYD K219
Y225-p
KkPALGFyDtsEENy
0 1
CDC5L (human) KkPALGFyDtsEENy Y225-p
CDC5L (mouse) KKPALGFYDtsEENY Y225
CDC5L (rat) KKPALGFYDTSEENY Y225
T227-p
PALGFyDtsEENyQA
1 14
CDC5L (human) PALGFyDtsEENyQA T227-p
CDC5L (mouse) PALGFYDtsEENYQA T227-p
CDC5L (rat) PALGFYDTSEENYQA T227
S228-p
ALGFyDtsEENyQAL
0 5
CDC5L (human) ALGFyDtsEENyQAL S228-p
CDC5L (mouse) ALGFYDtsEENYQAL S228-p
CDC5L (rat) ALGFYDTSEENYQAL S228
Y232-p
yDtsEENyQALDADF
0 62
CDC5L (human) yDtsEENyQALDADF Y232-p
CDC5L (mouse) YDtsEENYQALDADF Y232
CDC5L (rat) YDTSEENYQALDADF Y232
R252-m1
QDLDGELrsEKEGRD
0 1
CDC5L (human) QDLDGELrsEKEGRD R252-m1
CDC5L (mouse) QDLDGELRSEKEGRD R252
CDC5L (rat) QDLDGELRSEKEGRD R252
S253-p
DLDGELrsEKEGRDR
0 2
CDC5L (human) DLDGELrsEKEGRDR S253-p
CDC5L (mouse) DLDGELRSEKEGRDR S253
CDC5L (rat) DLDGELRSEKEGRDR S253
S273-p
HLKRKKEsDLPsAIL
0 2
CDC5L (human) HLKRKKEsDLPsAIL S273-p
CDC5L (mouse) HLKRKKEsDLPSAIL S273-p
CDC5L (rat) HLKRKKESDLPSAIL S273
S277-p
KKEsDLPsAILQTSG
0 1
CDC5L (human) KKEsDLPsAILQTSG S277-p
CDC5L (mouse) KKEsDLPSAILQTSG S277
CDC5L (rat) KKESDLPSAILQTSG S277
K294
EFTKKRSKLVLPAPQ
0 1
CDC5L (human) EFTKKRSKLVLPAPQ K294
CDC5L (mouse) EFTKKRSkLVLPAPQ K294-ub
CDC5L (rat) EFTKKRSKLVLPAPQ K294
S303-p
VLPAPQIsDAELQEV
Upstream
1 32
Treatment
  • EGF
  • nocodazole
CDC5L (human) VLPAPQIsDAELQEV S303-p
CDC5L (mouse) VLPAPQIsDAELQEV S303-p
CDC5L (rat) VLPAPQISDAELQEV S303
S317-p
VVKVGQAsEIARQTA
0 1
CDC5L (human) VVKVGQAsEIARQTA S317-p
CDC5L (mouse) VVKVGQASEVARQTA S317
CDC5L (rat) VVKVGQASEVARQTA S317
T344-p
LLSEYNVtNNsVALR
0 2
CDC5L (human) LLSEYNVtNNsVALR T344-p
CDC5L (mouse) LLSEYNVTNNSIALR T344
CDC5L (rat) LLSEYNVTNNSIALR T344
S347-p
EYNVtNNsVALRtPR
0 2
CDC5L (human) EYNVtNNsVALRtPR S347-p
CDC5L (mouse) EYNVTNNSIALRTPR S347
CDC5L (rat) EYNVTNNSIALRTPR S347
T352-p
NNsVALRtPRtPAsQ
0 11
CDC5L (human) NNsVALRtPRtPAsQ T352-p
CDC5L (mouse) NNSIALRTPRtPASQ T352
CDC5L (rat) NNSIALRTPRTPASQ T352
T355-p
VALRtPRtPAsQDRI
0 16
CDC5L (human) VALRtPRtPAsQDRI T355-p
CDC5L (mouse) IALRTPRtPASQDRI T355-p
CDC5L (rat) IALRTPRTPASQDRI T355
S358-p
RtPRtPAsQDRILQE
1 5
CDC5L (human) RtPRtPAsQDRILQE S358-p
CDC5L (mouse) RTPRtPASQDRILQE S358
CDC5L (rat) RTPRTPASQDRILQE S358
T373-p
AQNLMALtNVDtPLk
0 9
CDC5L (human) AQNLMALtNVDtPLk T373-p
CDC5L (mouse) AQNLMALtNVDtPLK T373-p
CDC5L (rat) AQNLMALTNVDtPLK T373
T377-p
MALtNVDtPLkGGLN
Upstream
0 38
Treatment
  • nocodazole
CDC5L (human) MALtNVDtPLkGGLN T377-p
CDC5L (mouse) MALtNVDtPLKGGLN T377-p
CDC5L (rat) MALTNVDtPLKGGLN T377-p
K380-ub
tNVDtPLkGGLNtPL
0 2
CDC5L (human) tNVDtPLkGGLNtPL K380-ub
CDC5L (mouse) tNVDtPLKGGLNtPL K380
CDC5L (rat) TNVDtPLKGGLNtPL K380
T385-p
PLkGGLNtPLHEsdF
Upstream
1 68
Treatment
  • MLN8054
  • nocodazole
CDC5L (human) PLkGGLNtPLHEsdF T385-p
CDC5L (mouse) PLKGGLNtPLHEsDF T385-p
CDC5L (rat) PLKGGLNtPLHESDF T385-p
S390-p
LNtPLHEsdFsGVtP
0 14
CDC5L (human) LNtPLHEsdFsGVtP S390-p
CDC5L (mouse) LNtPLHEsDFsGVtP S390-p
CDC5L (rat) LNtPLHESDFSGVtP S390
D391-ca
NtPLHEsdFsGVtPQ
0 1
CDC5L (human) NtPLHEsdFsGVtPQ D391-ca
CDC5L (mouse) NtPLHEsDFsGVtPQ D391
CDC5L (rat) NtPLHESDFSGVtPQ D391
S393-p
PLHEsdFsGVtPQRQ
0 4
CDC5L (human) PLHEsdFsGVtPQRQ S393-p
CDC5L (mouse) PLHEsDFsGVtPQRQ S393-p
CDC5L (rat) PLHESDFSGVtPQRQ S393
T396-p
EsdFsGVtPQRQVVQ
Upstream
0 70
Treatment
  • BI_4834
  • nocodazole
CDC5L (human) EsdFsGVtPQRQVVQ T396-p
CDC5L (mouse) EsDFsGVtPQRQVVQ T396-p
CDC5L (rat) ESDFSGVtPQRQVVQ T396-p
T404-p
PQRQVVQtPNtVLst
Upstream
1 45
Treatment
  • ischemia
CDC5L (human) PQRQVVQtPNtVLst T404-p
CDC5L (mouse) PQRQVVQtPNTVLst T404-p
CDC5L (rat) PQRQVVQTPNTVLST T404
T407-p
QVVQtPNtVLstPFR
0 9
CDC5L (human) QVVQtPNtVLstPFR T407-p
CDC5L (mouse) QVVQtPNTVLstPFR T407
CDC5L (rat) QVVQTPNTVLSTPFR T407
S410-p
QtPNtVLstPFRtPs
0 14
CDC5L (human) QtPNtVLstPFRtPs S410-p
CDC5L (mouse) QtPNTVLstPFRtPs S410-p
CDC5L (rat) QTPNTVLSTPFRTPS S410
T411-p
tPNtVLstPFRtPsN
Downstream
1 36
Effects on Biological Processes:
  • RNA splicing, altered
CDC5L (human) tPNtVLstPFRtPsN T411-p
CDC5L (mouse) tPNTVLstPFRtPsN T411-p
CDC5L (rat) TPNTVLSTPFRTPSN T411
T415-p
VLstPFRtPsNGAEG
0 55
CDC5L (human) VLstPFRtPsNGAEG T415-p
CDC5L (mouse) VLstPFRtPsNGAEG T415-p
CDC5L (rat) VLSTPFRTPSNGAEG T415
S417-p
stPFRtPsNGAEGLt
1 14
CDC5L (human) stPFRtPsNGAEGLt S417-p
CDC5L (mouse) stPFRtPsNGAEGLt S417-p
CDC5L (rat) STPFRTPSNGAEGLt S417
T424-p
sNGAEGLtPRsGttP
Upstream
1 111
Treatment
  • BI2536
  • MLN8054
  • nocodazole
CDC5L (human) sNGAEGLtPRsGttP T424-p
CDC5L (mouse) sNGAEGLtPRSGttP T424-p
CDC5L (rat) SNGAEGLtPRSGTTP T424-p
S427-p
AEGLtPRsGttPkPV
0 6
CDC5L (human) AEGLtPRsGttPkPV S427-p
CDC5L (mouse) AEGLtPRSGttPKPV S427
CDC5L (rat) AEGLtPRSGTTPKPV S427
T429-p
GLtPRsGttPkPVIN
0 6
CDC5L (human) GLtPRsGttPkPVIN T429-p
CDC5L (mouse) GLtPRSGttPKPVTN T429-p
CDC5L (rat) GLtPRSGTTPKPVTN T429
T430-p
LtPRsGttPkPVINs
Upstream
0 23
Treatment
  • MLN8054
CDC5L (human) LtPRsGttPkPVINs T430-p
CDC5L (mouse) LtPRSGttPKPVTNA T430-p
CDC5L (rat) LtPRSGTTPKPVTNA T430
K432-ub
PRsGttPkPVINstP
0 1
CDC5L (human) PRsGttPkPVINstP K432-ub
CDC5L (mouse) PRSGttPKPVTNAtP K432
CDC5L (rat) PRSGTTPKPVTNATP K432
S437-p
tPkPVINstPGRtPL
0 22
CDC5L (human) tPkPVINstPGRtPL S437-p
CDC5L (mouse) tPKPVTNAtPGRtPL A437
CDC5L (rat) TPKPVTNATPGRTPL A437
T438-p
PkPVINstPGRtPLR
Downstream
1 35
Effects on Biological Processes:
  • RNA splicing, altered
CDC5L (human) PkPVINstPGRtPLR T438-p
CDC5L (mouse) PKPVTNAtPGRtPLR T438-p
CDC5L (rat) PKPVTNATPGRTPLR T438
T442-p
INstPGRtPLRDkLN
Upstream
0 37
Treatment
  • MLN8054
CDC5L (human) INstPGRtPLRDkLN T442-p
CDC5L (mouse) TNAtPGRtPLRDKLN T442-p
CDC5L (rat) TNATPGRTPLRDKLN T442
K447-ub
GRtPLRDkLNINPED
0 1
CDC5L (human) GRtPLRDkLNINPED K447-ub
CDC5L (mouse) GRtPLRDKLNINPED K447
CDC5L (rat) GRTPLRDKLNINPED K447
Y459-p
PEDGMADysDPsyVk
0 31
CDC5L (human) PEDGMADysDPsyVk Y459-p
CDC5L (mouse) PEDGMADYSDPSYVk Y459
CDC5L (rat) PEDGMADYSDPSYVK Y459
S460-p
EDGMADysDPsyVkQ
0 16
CDC5L (human) EDGMADysDPsyVkQ S460-p
CDC5L (mouse) EDGMADYSDPSYVkQ S460
CDC5L (rat) EDGMADYSDPSYVKQ S460
S463-p
MADysDPsyVkQMER
0 1
CDC5L (human) MADysDPsyVkQMER S463-p
CDC5L (mouse) MADYSDPSYVkQMER S463
CDC5L (rat) MADYSDPSYVKQMER S463
Y464-p
ADysDPsyVkQMERE
0 3
CDC5L (human) ADysDPsyVkQMERE Y464-p
CDC5L (mouse) ADYSDPSYVkQMERE Y464
CDC5L (rat) ADYSDPSYVKQMERE Y464
K466-ub
ysDPsyVkQMERESR
0 2
CDC5L (human) ysDPsyVkQMERESR K466-ub
CDC5L (mouse) YSDPSYVkQMERESR K466-ub
CDC5L (rat) YSDPSYVKQMERESR K466
K487-ub
LLGLPAPkNDFEIVL
0 1
CDC5L (human) LLGLPAPkNDFEIVL K487-ub
CDC5L (mouse) LLGLPAPKNDFEIVL K487
CDC5L (rat) LLGLPAPKNDFEIVL K487
K500-ub
VLPENAEkELEEREI
0 1
CDC5L (human) VLPENAEkELEEREI K500-ub
CDC5L (mouse) VLPENAEKELEEREI K500
CDC5L (rat) VLPENAEKELEEREM K500
T510-p
EEREIDDtyIEDAAD
0 2
CDC5L (human) EEREIDDtyIEDAAD T510-p
CDC5L (mouse) EEREIDDTYIEDAAD T510
CDC5L (rat) EEREMDDTYIEDAAD T510
Y511-p
EREIDDtyIEDAADV
0 10
CDC5L (human) EREIDDtyIEDAADV Y511-p
CDC5L (mouse) EREIDDTYIEDAADV Y511
CDC5L (rat) EREMDDTYIEDAADV Y511
Y621-p
TYLEHNPyEkFSkEE
0 1
CDC5L (human) TYLEHNPyEkFSkEE Y621-p
CDC5L (mouse) TYLEHSPYEKFSKED Y621
CDC5L (rat) TYLEHSPYEKFSKED Y621
K623-ub
LEHNPyEkFSkEELK
0 1
CDC5L (human) LEHNPyEkFSkEELK K623-ub
CDC5L (mouse) LEHSPYEKFSKEDLK K623
CDC5L (rat) LEHSPYEKFSKEDLK K623
K626-ac
NPyEkFSkEELKKAQ
0 1
CDC5L (human) NPyEkFSkEELKKAQ K626-ac
CDC5L (mouse) SPYEKFSKEDLKKAQ K626
CDC5L (rat) SPYEKFSKEDLKKAQ K626
S691-p
SKKDRIEsLEkRLEI
0 1
CDC5L (human) SKKDRIEsLEkRLEI S691-p
CDC5L (mouse) SKKDRIESLEKRLEI S691
CDC5L (rat) SKKDRIESLEKRLEI S691
K694-ub
DRIEsLEkRLEINRG
0 1
CDC5L (human) DRIEsLEkRLEINRG K694-ub
CDC5L (mouse) DRIESLEKRLEINRG K694
CDC5L (rat) DRIESLEKRLEINRG K694
Y788-p
EKELQHRyADLLLEk
0 1
CDC5L (human) EKELQHRyADLLLEk Y788-p
CDC5L (mouse) EKELQQRYADLLMEK Y788
CDC5L (rat) EKELQQRYADLLMEK Y788
K795-ub
yADLLLEkEtLKSKF
0 1
CDC5L (human) yADLLLEkEtLKSKF K795-ub
CDC5L (mouse) YADLLMEKETLQAKF K795
CDC5L (rat) YADLLMEKETLQAKF K795
T797-p
DLLLEkEtLKSKF__
0 1
CDC5L (human) DLLLEkEtLKSKF__ T797-p
CDC5L (mouse) DLLMEKETLQAKF__ T797
CDC5L (rat) DLLMEKETLQAKF__ T797